PLATELET ALPHA-2-ADRENERGIC RECEPTOR-BINDING SITES IN MAJOR DEPRESSIVE DISORDER AND BORDERLINE PERSONALITY-DISORDER

被引:13
|
作者
SOUTHWICK, SM
YEHUDA, R
GILLER, EL
PERRY, BD
机构
[1] UNIV CHICAGO, DEPT PSYCHIAT,CHILD & ADOLESCENT PSYCHIAT SECT, BOX 411,5841 S MARYLAND AVE, CHICAGO, IL 60637 USA
[2] UNIV CONNECTICUT, CTR HLTH, UNIV HOSP PROGRAMS, FARMINGTON, CT 06032 USA
[3] VET ADM MED CTR, POSTRAUMAT STRESS DISORDER PROGRAM, W HAVEN, CT 06516 USA
[4] NATL CTR POSTRAUMAT STRESS DISORDER, DIV CLIN NEUROSCI, NEW HAVEN, CT USA
[5] YALE UNIV, SCH MED, PSYCHIAT, NEW HAVEN, CT 06510 USA
[6] UNIV CONNECTICUT, CTR HLTH, PSYCHIAT PSYCHOL, FARMINGTON, CT 06032 USA
[7] VET ADM MED CTR, PSYCHIAT SERV, W HAVEN, CT 06516 USA
[8] UNIV CONNECTICUT, CTR HLTH, PSYCHIAT, FARMINGTON, CT 06032 USA
关键词
!sup]3[!/sup]H-rauwolscine; borderline personality disorder; catecholamines; major depressive disorder; Platelet α[!sub]2[!/sub]-adrenergic receptor binding; radioligand binding studies;
D O I
10.1016/0165-1781(90)90019-2
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Platelet α2-adrenergic receptor binding sites were measured in a group of patients with major depressive disorder (MDD) (n = 23) and in normal controls (n = 25). When all depressed subjects were compared to controls, there were no differences in either Kd (affinity of the ligand) or total binding site (number/platelet), although a significant change in the ratio of high to low affinity states was observed in the depressed group. When the depressed patients were subdivided into those with and without a co-occuring borderline personality disorder (BPD), the BPD group had significantly fewer α2 high affinity binding sites, while the group with depression alone had significantly more binding sites (both low and high affinity) than the control group. The results support the concept that assessment of comorbid diagnoses may be essential to biological studies of depression. © 1990.
引用
收藏
页码:193 / 203
页数:11
相关论文
共 50 条
  • [41] Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder
    N. M. K. Ng Ying Kin
    Joel Paris
    George Schwartz
    Hallie Zweig-Frank
    Howard Steiger
    N. P. V. Nair
    Psychopharmacology, 2005, 182 : 447 - 451
  • [42] Biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression
    De la Fuente, JM
    Bobes, J
    Vizuete, C
    Mendlewicz, J
    JOURNAL OF PSYCHIATRIC RESEARCH, 2002, 36 (03) : 137 - 145
  • [43] Use of structured self-report assessment to diagnose borderline personality disorder during major depressive episodes
    Kurtz, JE
    Morey, LC
    ASSESSMENT, 2001, 8 (03) : 291 - 300
  • [44] Bipolar disorder correlated to shorter remission latency and borderline personality disorder symptom severity to longer in depression - a prospective cohort study of major depressive patients
    Soderholm, J.
    Socada, L.
    Rosenstrom, T.
    Ekelund, J.
    Isometsa, E.
    EUROPEAN PSYCHIATRY, 2022, 65 : S85 - S86
  • [45] The role of borderline personality disorder traits in predicting longitudinal variability of major depressive symptoms among a sample of depressed adults
    Kline, Emily A.
    Lekkas, Damien
    Bryan, Anastasia
    Nemesure, Matthew D.
    Griffin, Tess Z.
    Collins, Amanda C.
    Price, George D.
    Heinz, Michael, V
    Nepal, Subigya
    Pillai, Arvind
    Campbell, Andrew T.
    Jacobson, Nicholas C.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 363 : 492 - 500
  • [46] Association of the adrenergic alpha 2a receptor-1291C/G polymorphism with weight change and treatment response to mirtazapine in patients with major depressive disorder
    Lee, Hwa-Young
    Kang, Rhee-Hun
    Paik, Jong-Woo
    Jeong, Yoo Jung
    Chang, Hun Soo
    Han, Sang-Woo
    Lee, Min-Soo
    BRAIN RESEARCH, 2009, 1262 : 1 - 6
  • [47] Functional Noncoding Variants From Several Major Depressive Disorder GWAS Loci Alter Retinoic Acid Receptor Family Binding Sites
    Castillo, Monica Feliz
    Fatourou, Evangelia
    Halaris, Angelos
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 183 - 184
  • [48] Is comorbid borderline personality disorder in patients with major depressive episode and bipolarity a developmental subtype? Findings from the international BRIDGE study
    Perugi, Giulio
    Angst, Jules
    Azorin, Jean-Michel
    Bowden, Charles
    Vieta, Eduard
    Young, Allan H.
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 144 (1-2) : 72 - 78
  • [49] P2X7 Receptor as a Potential Target for Major Depressive Disorder
    Huang, Zeyi
    Tan, Sijie
    CURRENT DRUG TARGETS, 2021, 22 (10) : 1108 - 1120
  • [50] Platelet 5-HT1A receptor correlates with major depressive disorder in drug-free patients
    Zhang, Zhang-Jin
    Wang, Di
    Man, Sui Cheung
    Ng, Roger
    McAlonan, Grainne M.
    Wong, Hei Kiu
    Wong, Wendy
    Lee, Jade
    Tan, Qing-Rong
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2014, 53 : 74 - 79